A Clinical Study to Evaluate the Efficacy, Safety, and Tolerability of TERN-601 in Adults With Overweight or Obesity

Phase 2 Completed 167 enrolled Terns, Inc.

RandomizedParallel-groupQuadruple-blindTreatment

Summary

This is a Phase 2a multicenter, randomized, double-blind, placebo-controlled clinical trial studying the efficacy, safety, and tolerability of orally administered TERN-601 in adults with overweight or obesity.

Timeline

Start: 2025-03-07
Primary completion: 2025-08-19
Completion: 2025-09-19

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	TERN-601	Unknown	—	Oral

A Clinical Study to Evaluate the Efficacy, Safety, and Tolerability of TERN-601 in Adults With Overweight or Obesity

Summary

Timeline

Drugs

Indications